Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Oct 27;5:38. doi: 10.1186/2041-9139-5-38

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Berni et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Rp-cact expression and knockdown phenotypes. (A) Normalized mRNA levels for Rp-cact show small variability throughout embryonic development. (B) Rp-cact mRNAs in stage 1A embryos (0 to 6 hours) are mostly maternally provided, while gastrulation stage 2B (18 to 24 hours) mRNAs are generated zygotically, since levels of the former are unaltered, while the latter are decreased in unfertilized eggs (non fert). (C) Rp-cact is also expressed in the immune tissues of the midgut and fat body. (D) In immune tissues such as the gut, Rp-cact levels respond to activation of the Toll pathway using zymosan. (E,F) Ovaries resulting from control MalE (E) or Rp-cact (F) pRNAi show that egg chambers do not develop in the Rp-cact knockdown.